상세 보기
Interim safety analysis from a randomized, open-label, multicenter, phase III trial of capecitabine plus oxaliplatin (XELOX) versus capecitabine (X) as first-line chemotherapy in elderly patients with advanced gastric cancer (AGC).
- Hwang, In Gyu;
- Kang, Jung Hun;
- Lee, Soonil;
- Lee, Hyo Rak;
- Lee, Hui Young;
- ... Lee, Jeeyun;
- 외 6명
Citations
WEB OF SCIENCE
0- 제목
- Interim safety analysis from a randomized, open-label, multicenter, phase III trial of capecitabine plus oxaliplatin (XELOX) versus capecitabine (X) as first-line chemotherapy in elderly patients with advanced gastric cancer (AGC).
- 저자
- Hwang, In Gyu; Kang, Jung Hun; Lee, Soonil; Lee, Hyo Rak; Lee, Hui Young; Ji, Jun Ho; Lee, Jeeyun; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Kang, Won Ki
- 발행일
- 2014-01
- 유형
- Meeting Abstract
- 권
- 32
- 호
- 3
- 언어
- ENG
- 출판사
- AMER SOC CLINICAL ONCOLOGY
- 발행국가
- 미국
- ISSN
- E 1527-7755
P 0732-183X